Skip to main content

NORGES BANK

Bank

Position in RPRX — Royalty Pharma plc

CIK 1374170 OSLO, Q8

Position in RPRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$299,194,229
+$167,270,894 QoQ
Shares Held
5,336,084
+56.3% QoQ
Ownership
0.928%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#12
of 635 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. RPRX ranks #8 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 RPRX
Royalty Pharma plc
This page
5,336,084 $299,194,229

All Filings in RPRX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $299,194,229 5,336,084
2025-12-31 $131,923,335 3,414,165
2025-06-30 $181,388,315 5,034,369
2025-03-31 $152,344,492 4,893,816
2024-12-31 $124,497,626 4,880,346
2024-09-30 $136,056,313 4,809,343
2024-06-30 $126,822,374 4,809,343
2024-03-31 $136,666,852 4,500,061
2023-12-31 $119,740,254 4,262,736
2023-09-30 $112,260,186 4,136,337
2023-06-30 $125,946,421 4,097,151
2023-03-31 $157,368,519 4,367,708
2022-12-31 $150,822,428 3,816,357
2022-09-30 $140,533,728 3,497,604
2022-06-30 $142,662,613 3,393,497
2022-03-31 $119,661,588 3,071,396
2021-12-31 $117,965,564 2,960,240
2021-09-30 $103,386,782 2,860,730
2021-06-30 $114,565,082 2,794,952
2021-03-31 $120,528,035 2,763,137
2020-12-31 $51,179,678 1,022,571
2020-09-30 $30,389,811 722,363
2020-06-30 $111,786,763 2,302,508